As an illustration, in cases of colorectal cancer, tumor development typically requires the introduction of 200–500 EpCAM-high/CD44+ cells; in contrast, injection of 104 EpCAM-low/CD44− cells cannot induce tumor formation [292]. This evidence concerns the gene EPCAM and colorectal cancer.